Ryan Martins - Feb 9, 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Financial Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins
Stock symbol
ETNB
Transactions as of
Feb 9, 2023
Transactions value $
$0
Form type
4
Date filed
2/13/2023, 04:43 PM
Previous filing
Feb 10, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +30K +91.27% $0.00 62.9K Feb 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +110K $0.00 110K Feb 9, 2023 Common Stock 110K $14.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest with respect to one-third of the underlying shares on February 9, 2024, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
F2 This option represents a right to purchase a total of 110,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 9, 2024, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.